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Background: Postoperative pain control after total knee arthroplasty (TKA) remains a great challenge. The
management of pain in the immediate postoperative period is one of the most critical aspects to allow speedier
rehabilitation and reduce the risk of postoperative complications. Recently, periarticular infiltration anesthesia has
become popular, but the outcome is controversial. Some studies have shown transient effects, “rebound pain”, or
no effectiveness in pain control. Continuous intra-articular infusion technique has been introduced to improve
these transient effects, but more clinical studies are needed. Furthermore, the potential risk of early periprosthetic
joint infection is causing concerning. We plan to compare continuous intra-articular infusion anesthesia with epidural
infusion anesthesia after TKA to assess the effectiveness of this technique in reducing pain, in improving postoperative
function, and to look at the evidence for risk of early infection.
Methods/design: This trial is a randomized, controlled study. Patients (n = 214) will be randomized into two groups: to
receive continuous intra-articular infusion anesthesia (group C); and epidural infusion anesthesia (group E). For the first
3 postoperative days, pain at rest, active range of motion (A-ROM), rescue analgesia and side effects will be recorded.
At 3-month and 6-month follow-up, A-ROM, C-reactive protein, erythrocyte sedimentation rate, and synovial fluid cell
count and culture will be analyzed.
Discussion: The results from this study will provide clinical evidence on the efficacy of a continuous intra-articular
infusion technique in reducing pain, postoperative functional improvement and safety. It will be the first randomized
controlled trial to investigate infection risk with local anesthesia after TKA.
Trial registration: ClinicalTrials.gov identifier: ChiCTR-TRC-13003999
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Randomized controlled trialBackground
Pain after total knee arthroplasty (TKA) is usually severe.
It causes a state of discomfort that may directly influence
patients' functional recovery. The pain involved has spe-
cific characteristics: a 55 to 60% incidence at rest and up
to70% upon mobilization; high or very high intensity; and
pain peaking at 3 to 6 hours after surgery and continuing
for the following 72 hours [1,2]. Anesthetic techniques
such as epidural analgesia or peripheral nerve block may* Correspondence: liujun.gdtcm@hotmail.com
1Department of Orthopedic Surgery, The Second School of Clinical Medicine,
Guangzhou University of Chinese Medicine, No. 111 Dade Road, Guangzhou,
Guangdong 510120, China
Full list of author information is available at the end of the article
© 2014 Guo et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.reach effective analgesic levels [3-5] in combination with
opioid analgesics and non-steroidal anti-inflammatory
drugs. Both techniques either have significant demands on
technical skills, have potential side effects, or are costly
[6-8]. Recently, local anesthesia techniques have become
popular, including: (1) periarticular infiltration with or
without local intermittent administration of anesthetics
with an intra-articular catheter [6,7,9-12]; and (2) a com-
bined technique with infiltration plus continuous infusion
[8,13,14]. Local anesthesia has shown several advantages
(less intensity of postoperative pain, less consumption of
rescue analgesics and earlier discharge) when compared to
other regional or purely systemic approaches [15-17].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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infiltration anesthesia. Some studies, using single-dose or
combined-dose periarticular infiltration, have shown tran-
sient effects, “rebound pain”, or no effectiveness in pain
control [12,18-21]. The continuous intra-articular infusion
technique has been introduced to improve these transient
effects. Two previous studies [8,14] using continuous
intra-articular infusion anesthesia showed better pain relief
and less opioid use than a control group using saline
infusion. Further investigation is needed to assess the
efficacy of continuous intra-articular infusion anesthesia.
One of the most concerning issues is whether continuous
intra-articular infusion would increase the risk of early
periprosthetic joint infection (PJI). Early diagnosis of PJI is
challenging; at the present time, diagnosis of PJI remains
dependent on clinical judgment and reliance on standard
clinical tests including serologic tests, analysis of aspirated
joint fluid, and interpretation of intraoperative tissue and
fluid test results.
For this purpose, the aims of our study were: (1) to
analyze the efficacy of continuous intra-articular infusion
anesthesia in postoperative pain control and functional
recovery compared with epidural analgesia; and (2) to
investigate PJI markers, such as erythrocyte sedimentation
rate (ESR), C-reactive protein (CRP), synovial fluid cell
count and culture during follow-up, to determine whether
the risk of early PJI increases with a continuous intra-
articular infusion procedure.Methods/design
Study design
This is a randomized, controlled prospective study. The
trial protocol has been approved by the Research Ethical
Committee of Guangdong Provincial Hospital of Trad-
itional Chinese Medicine (TCM) (reference, B2011-38-01).
The trial will be conducted in accordance with the Helsinki
Declaration, and will be monitored by the trial agency at
Guangdong Provincial Hospital of TCM.Recruitment and consent
Patients scheduled for primary TKA at the Department
of Orthopedic Surgery, Guang Dong Provincial Hospital
of TCM, will be recruited, with a target sample size of
214 subjects. All candidates will go through a standardized
interview process and receive more information about
the study and the treatments. The participants’ written
consents will be obtained. The purpose and procedures,
and potential risks and benefits, of the study will also
be explained thoroughly to the participants. Participants
are able to withdraw from the study at any time without
consequence. The trial will be executed from February
2014 to December 2015 including enrollment and follow-
up (Figure 1).Inclusion criteria
Participants meeting the following criteria will be included:
 Meet the diagnostic criteria for knee osteoarthritis;
 Planned spinal anesthesia; American Society of
Anesthesiologists (ASA) physical status I-II;
 Scheduled for unilateral TKA;
 Patients aged 50 to 80 years old.
 Willingness to give written informed consent and
willingness to participate in and comply with the study.
Exclusion criteria
Participants meeting one or more of the following criteria
will be excluded:
 Unwillingness of the patient;
 Presence of neuropathic pain or sensory disorders in
the leg to be operated on;
 Intolerance to the study drugs;
 Failure of spinal anesthesia;
 Previous major knee surgery, re-operation or trauma
to the knee within the study period.
Interventions
All recruited patients will receive combined spinal and
epidural anesthesia at the L3-4 level. For all the patients,
cefamandole (2 g) will be administered intravenously 30
minutes before and after surgery. Low-molecular-weight
heparin (4,500 U) for thromboprophylaxis will be admin-
istered subcutaneously 8 hours postoperatively and then
once daily until week 2. In group E, the heparin adminis-
tration will be delayed until epidural catheter withdrawal
on postoperative day (POD) 2. A standardized intraopera-
tive regimen for fluid administration will be applied which
consists of 0.9% saline at 5 ml/kg per hour and colloid
(Voluven; Fresenius Kabi, Bad Homburg, Germany) at
7.5 ml/kg per hour.
For multi-model pain management, preoperative oral
doses of 400 mg celecoxib daily will be administered from
day 2 before surgery. Postoperatively, all patients will re-
ceive 40 mg of parecoxib sodium twice daily intravenously
until POD 3, followed by oral doses of 200 mg celecoxib
every 12 hours until discharge. Tramadol hydrochloride
injection will be applied for rescue analgesia.
The same surgeon will perform all operations. A Gemini
MK II prosthesis (LINK, Hamburg, Germany) will be
inserted via a standard medial parapatellar approach in
all patients.
Cocktail anesthetic preparation
Cocktail anesthetic will be prepared for continuous
intra-articular infusion, containing 150 mg ropivacaine
(20 ml), 3 mg morphine sulfate (0.3 ml), 30 mg ketoro-
lac tromethamine (1 ml), 0.5 μg 1:1000 epinephrine
Figure 1 Flow-chart of the study.
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of 150 ml.
Continuous intra-articular infusion anesthesia group (group C)
In group C, 50 ml of cocktail anesthetic will be applied via
periarticular infiltration before insertion of the prosthesis.
A multi-holed catheter will be placed into the lateral
parapatellar gutter. The remaining 100 ml will be used
as continuous intra-articular infusion with a patient-
controlled analgesic (PCA) pump (Fornia, Zhuhai, China)
at a speed of 2 ml/hour. After the wound is sutured, the
catheter will be connected to the PCA pump which is
activated after surgery and removed 48 hours later. The
PCA pump will be set to deliver a 0.5-ml dose with a
15-minute lockout interval.
Epidural infusion anesthesia group (group E)
In group E, the epidural catheter position will be checked
with a test dose of 3 ml lidocaine-adrenalin (20 mg/ml
and 5 μg/ml), followed by a bolus of 7 ml ropivacaine(2 mg/ml). A PCA pump containing 200 mg of ropiva-
caine (2 mg/ml) and 4 mg of morphine (0.04 mg/ml) will
be connected with a flow rate of 2 ml/hour for 48 hours
postoperatively. The PCA will be programmed to provide
a 0.5-ml dose with a lockout interval of 15 minutes.Randomization and blinding
Random assignment was performed before surgery by
using a computer generated, blocked random-allocation
sequence with a 1:1 ratio. This study cannot be blinded
because the different catheter placement is obvious.Primary outcome measures
Visual analogue scale
The visual analog scale (VAS) has been used extensively
for rating pain intensity in previous studies [22-24].
Postoperative pain at 2, 6, 10, 18, 26, 34, 42, 50, 58, 64,
and 72 hours after surgery will be recorded using a VAS.
The VAS consists of a 10-cm horizontal line with 1-cm
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"worst possible pain" (right side).
Rescue analgesia frequency and consumption
Usually the need for supplementary treatment with sys-
temic opioids is a reliable indicator when concerned
about postoperative pain control. In previous studies, it
has been argued that the use of strong or long-term
rescue analgesia in both treatment groups may have
reduced pain too much and “washed out” any differences
between the two treatments. In this study, we use tramadol
hydrochloride injection, which is a mid-intensity analgesic
that will facilitate observing the differences in pain control
between groups. The frequency and total consumption
during the first 3 postoperative days will be recorded.
Active range of motion
Traditionally, range of motion has been used as an out-
come measure after TKA to evaluate functional recovery
and the success of the type of analgesia used [4-6,12].
However, we think active range of motion (A-ROM)
represents a more realistic criterion for assessment of
functioning and analgesia efficiency after TKA. A-ROM
will be measured in the first 3 postoperative days and
at the 3-month and 6-month follow-up.
Secondary outcome measures
Periprosthetic joint infection markers
Early diagnosis of PJI is challenging; at the present time,
diagnosis of PJI remains dependent on clinical judgment
and reliance on standard clinical tests including serologic
tests, analysis of aspirated joint fluid, and interpretation
of intraoperative tissue and fluid test results. During 3-
month and 6-month follow-up, the CRP, ESR, synovial
fluid culture, white blood cell (WBC) count and poly-
morphonuclear cell percentage (%PMN) will be measured.
Safety
The presence of side effects during the postoperative
period will be recorded, including nausea, vomiting,
constipation and other adverse events.
Sample size
Calculation of sample size was based on two previous
studies [20,25]. We assumed that postoperative pain
during the 24- to 48-hour period will reach peak value
and need effective pain control. Mean VAS scores over
24 to 48 hours for the two modes of analgesia were
extracted. Group sample sizes of 93 for each group will
achieve 80% power to detect a difference of 1.0 between
the null hypothesis that both group means are 2.8 and
the alternative hypothesis that the mean of group E is
1.8, with estimated group standard deviations of 3.1
and 1.4 and with a significance level (alpha) of 0.05using a two-sided t-test. We plan to enroll a total of
214 participants with 107 in each group, allowing for a
15% withdrawal rate.Data analysis
The statistical analysis will be performed using SPSS (Ver-
sion 17.0) software (SPSS Inc., Shanghai, China). Normally
distributed continuous variables will be compared using
Student’s t-test. VAS and A-ROM will be analyzed with
repeated measures for general linear models and multivari-
ate analysis of variance. Data will be expressed as means
(standard deviation), absolute numbers, and frequencies,
when appropriate. P < 0.05 will be considered statistically
significant for all comparisons.Discussion
This study will provide clinical evidence on the efficacy
of a continuous intra-articular infusion technique in
reducing pain and improving postoperative function. In
TKA, this remains a significant problem in the early
postoperative period. Reduction of the patient's discomfort
is the primary goal; reduction of the cost of narcotic use is
a secondary goal. The epidural analgesia has been regarded
as the gold standard in postoperative pain management,
and it is associated with potential problems such as motor
block, urinary retention and epidural bleeding (with antic-
oagulation therapy), and necessitates intensive observation
of patients. The primary purpose of our study is to evaluate
the efficacy of a continuous intra-articular infusion tech-
nique in relieving postoperative pain, reducing the need for
postoperative narcotics, and improvement in postoperative
function.
This study will be the first randomized controlled trial to
investigate infection risk with a continuous intra-articular
infusion technique after TKA. There has been concern
about the risk of early PJI with periarticular multimodal
drug injection and use of intra-articular catheters after
TKA. Previous studies of local infiltration analgesia after
unicompartmental knee arthroplasty or TKA have not
found any increase in infection [7,15,20,26], but the
evidence has been weak in most studies. At the
present time, diagnosis of PJI remains dependent on
clinical judgment and reliance on standard clinical
tests including serologic tests and analysis of aspirated
joint fluid. For this purpose, we will measure the ESR,
CRP, synovial fluid cultures, WBC count, and %PMN
at the 3-month and 6-month follow-up to identify
early infections related to the surgical procedure.Trial status
Recruitment will commence in February 2014, and the
trial is scheduled to end in December 2015.
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